Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation

Abstract

Fas is a cell‐surface protein which belongs to the tumor‐necrosis‐factor‐receptor family. Signals through Fas are able to induce apoptosis in sensitive cells, and thus modalities for regulating the level of Fas expression on tumor cells are needed. We have studied cellular responses to gamma irradiation. The level of p53 tumor‐suppressor protein was found to be elevated 3 hr after irradiation of p53wild‐type MCF‐7 breast‐carcinoma cells. Interestingly, accumulation of p53 was followed by up‐regulation of surface Fas levels between 4 and 8 hr after irradiation. The level of Fas up‐regulation was dependent on dose and, whereas elevation in the level of p53 was transient, enhancement of Fas expression was stable. Fas up‐regulation occurred coincidentally with induction of G1 cell‐cycle arrest, a post‐irradiation phenomenon known to be dependent on wild‐type‐p53 activity. We studied 9 other tumor lines, 2 with wild‐type p53, 5 with mutant p53, and 2 expressing no p53. All lines expressing wild‐type p53 were found to arrest in G1 and to up‐regulate Fas after irradiation. In contrast, all 7 p53null and p53mutant lines failed not only to arrest their cell cycles in G1 phase, but also to up‐regulate Fas levels in response to treatment. These findings demonstrate a direct correlation between wild‐type‐p53 activity and Fas up‐regulation after treatment with ionizing radiation, strongly suggesting that post‐irradiation Fas up‐regulation is dependent on wild‐type‐p53 activity. Since low doses of radiation were sufficient to modulate Fas expression, up‐regulation of the Fas death receptor may have clinical implications following radiotherapy. Int. J. Cancer 73:757–762, 1997. © 1997 Wiley‐Liss, Inc.

Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas

“…39 Radiotherapy up-regulates Fas in human p53 wt cancer cells. 40 Therefore, combined induction of p53 and FL is a good candidate for enhancing the therapeutic effect of chemotherapy as well as radiotherapy.…”

Expression of CD95 (Fas) in sun‐exposed human skin and cutaneous carcinomas

“…This down-regulation of Fas in advanced sun damage may represent the loss of proliferation control allowing for uncontrolled growth. Experimental data of Scheard et al 21 strongly indicated that Fas upregulation in cells treated with ionizing radiation is dependent on wild-type p53 activity. Fas overexpression coincides with G 1 cell cycle arrest, which is a known postirradiation p53-dependent phenomenon.…”

Enhancing efficacy of therapeutic vaccinations by combination with other modalities

“…Due to limits in toxicity, some tumor cells within a given tumor mass may receive a sublethal dose of radiation. This dose, however, may be capable of modulating numerous classes of genes, resulting in phenotypic alteration of the tumor cells [4][5][6]. Genes that have been shown to be up-regulated postirradiation in murine and/or human tumors include Fas, MHC class I, ICAM-1, and multiple TAAs.…”